UY30699A1 - SUBSTITUTED DERIVATIVES OF 4-PHENYLAMINE-QUINOLINA-3-CARBOXAMIDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS - Google Patents

SUBSTITUTED DERIVATIVES OF 4-PHENYLAMINE-QUINOLINA-3-CARBOXAMIDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS

Info

Publication number
UY30699A1
UY30699A1 UY30699A UY30699A UY30699A1 UY 30699 A1 UY30699 A1 UY 30699A1 UY 30699 A UY30699 A UY 30699A UY 30699 A UY30699 A UY 30699A UY 30699 A1 UY30699 A1 UY 30699A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutically acceptable
acceptable salts
compositions containing
carboxamids
quinolina
Prior art date
Application number
UY30699A
Other languages
Spanish (es)
Inventor
Scott David
Zheng Xiaolan
Daly Kevin
Leslie Dakin
David Del Valle
Thomas Gero
Claude Afona Ogoe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY30699A1 publication Critical patent/UY30699A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a compuestos químicos de formula (I): o sales farmacéuticamente aceptables de los mismos que poseen actividad inhibitoria quinasa de CSF-1R y son concordantemente utiles por su actividad anticancerígena y así en métodos de tratamiento del cuerpo humano o animal. La invencion se refiere también a procesos para la fabricacion de dichos compuestos químicos, a composiciones farmacéuticas que los contienen y a su uso en la fabricacion de medicamentos para uso en la produccion de un efecto anticancerígeno en un animal de sangre caliente como el hombre.The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof that possess CSF-1R kinase inhibitory activity and are accordingly useful for their anticancer activity and thus in methods of treating the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anticancer effect in a warm-blooded animal such as man.

UY30699A 2006-11-10 2007-11-08 SUBSTITUTED DERIVATIVES OF 4-PHENYLAMINE-QUINOLINA-3-CARBOXAMIDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS UY30699A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86524506P 2006-11-10 2006-11-10

Publications (1)

Publication Number Publication Date
UY30699A1 true UY30699A1 (en) 2008-07-03

Family

ID=39627438

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30699A UY30699A1 (en) 2006-11-10 2007-11-08 SUBSTITUTED DERIVATIVES OF 4-PHENYLAMINE-QUINOLINA-3-CARBOXAMIDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS

Country Status (4)

Country Link
CN (1) CN101611011A (en)
CL (1) CL2007003220A1 (en)
UY (1) UY30699A1 (en)
ZA (1) ZA200903100B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102584852B (en) * 2011-12-30 2014-08-13 厦门大学 Qiaonan mycin serving as fungus metabolism product and preparation method and application thereof
EP3246028A1 (en) * 2016-05-18 2017-11-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinoline compounds for increasing insuline release
CN109700798A (en) * 2017-03-01 2019-05-03 浙江大学 Chromene flavones structure type androgen receptor antagonists and its application
CN113087696A (en) * 2019-12-23 2021-07-09 江苏开元药业有限公司 Quinoline compound and application thereof

Also Published As

Publication number Publication date
ZA200903100B (en) 2010-04-28
CN101611011A (en) 2009-12-23
CL2007003220A1 (en) 2008-05-30

Similar Documents

Publication Publication Date Title
UY30282A1 (en) CHEMICAL COMPOUNDS
UY29300A1 (en) CHEMICAL COMPOUNDS
UY29092A1 (en) DERIVATIVES OF 4-OXO-3,4-DIHIDROQUINAZOLIN-6-CARBOXAMIDA, B-RAF INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
UY30547A1 (en) N-SUBSTITUTED DERIVATIVES OF 6-PIRIDIN-4-IL QUINAZOLIN-2-AMINA, ITS STEREOISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS, PREPARATION PROCESS, COMPOSITIONS AND APPLICATIONS.
ECSP099322A (en) CHEMICAL COMPOUNDS
UY31281A1 (en) AMINAS, BENZAMIDS AND SULFONAMIDS {[4- (5,6-DIMETIL-2-PIRIDIN-2-IL-PIRIDIN-3-IL) OXIPIRIDIN-2-IL] AMINO} SUBSTITUTED, ITS PHARMACUTICALLY ACCEPTABLE SALTS, COMPOSITIONS AND APPLIED APPLICATIONS.
UY28990A1 (en) NEW DERIVATIVES OF BENZENE 1, 3-CARBON AMINO AS B-RAF INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE PROCESSES.
UY30094A1 (en) CHEMICAL COMPOUNDS
UY29093A1 (en) DERIVATIVES OF 4-OXO-3. 4-DIHIDROQUINAZOLIN-6-CARBOXAMIDA, B-RAF INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS.
CO6470845A2 (en) NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND ADDITIONAL DISEASES
ECSP10010695A (en) PIRIDINE COMPOUNDS
ECSP099382A (en) HETEROCYCLIC SULFONAMIDS THAT HAVE EDG-I ANTAGONIST ACTIVITY
TW200635899A (en) Chemical compounds
CL2012000589A1 (en) Compounds derived from pyrrolo pyridine carboxamides, jak2 inhibitors; pharmaceutical composition comprising them; use in the treatment of myeloproliferative diseases or cancer, such as polycythemia vera, essential thrombocytopenia, multiple myeloma, among others.
CL2011000777A1 (en) Compounds derived from imidazopyridazine, protein kinase inhibitor; pharmaceutical composition comprising them; and its use in the treatment of cancer, psoriasis, rheumatoid arthritis, angiogenesis, among others.
ECSP12011622A (en) OXAZINE DERIVATIVES AND ITS USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
ECSP12012065A (en) DERIVATIVES OF PIRAZINA AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
ECSP088541A (en) [(1H-INDOL-5-IL) -HETEROARILOXI] - (1-AZA-BICICLO [3.3.1] NONANS AS N-ACHR COLLINERIC LINKS FOR THE TREATMENT OF PSYCHOTIC AND NEURODEGENERATIVE DISORDERS
UY28732A1 (en) ACID DERIVATIVES 7-PHENYLAMINE-4-QUINOLONA-3-CARBOXILICO, PROCESSES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
UY34955A (en) 4-METHYL-2,3,5,9,9B-PENTAAZA-CICLOPENTA [A] NAFTALENOS
NI201000145A (en) DERIVATIVES OF IMIDAZINE - [1, 2-b] - PYRIDAZINE FOR THE TREATMENT OF DISEASE MEDIATED BY TYROSINE KINASE C-MET.
UY30835A1 (en) 8-ALQUINILXANTINAS AND DERIVATIVES
ECSP099425A (en) DERIVATIVES OF AMINA AND ITS USE IN DISEASES MEDIATED BY THE BETA 2 ADRENORECETOR
ECSP099539A (en) DERIVATIVES OF 3-CINOLINACARBOXAMIDE AND ITS USE TO TREAT CANCER
UY32055A (en) Substituted derivatives of 5-Halo-N2- [substituted] (1-methyl-1H-imidazol-4-yl) pyrimidin-2, -diamine and its pharmaceutically acceptable salts, preparation processes, compositions and applications.

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20200710